References
- Silverman LB, Weintein HL. Treatment of childhood leukaemia. Curr Opin Oncology 1997; 9(1): 26–33.
- van Gool Sw, van Den Hove I, Ceuppens JI. Activation of the immune system in cancer patients. Med Pediatric Oncology 2000; 34(1): 1–9.
- Caver TE, Slobod KS, Flynn PM, et al. Profound abnormality of the BIT lymphocyte ratio during chemotherapy for pediatric acute Lymphoblastic leukaemia. Leukaemia 1998; 12: 619–622.
- Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cellsafter chemotherapy for childhood acute lymphoblastic leukaemia and solid tumors. Med Pediatr Oncol 1995; 24: 373–378.
- Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4 T-lymphocyte regeneration after intensive chemother-apy. N Eng J Med 1995; 332(3): 143–149.
- Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recoveryin children with malignancy after cessation of chemotherapy. J Pediatric Hematology Oncology 1998; 20(5): 451–457.
- Bostram BC, Sensel MR, Sather NH, et al. Dexamethasone versusprednisone and daily oral versus weekly intravenous mercapto-purine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 2003; 101(10): 3809–3817.
- Kostaridou S, Polychronopoulou S, Psarra K, et al. Decrease of CD4 and B-lymphocyte populations is not associated with severe infectious complications in children with acute lymphoblastic leukaemia during maintenance. Int .1 Hematol 2004; 80(4): 354–360.
- Luczynski W, Stasiak A, Krawczuk-Rybak. Immunological monitoring of maintenance therapy for acute lymphoblastic leukaemia in children — preliminary report. Pediatric Blood Cancer 2004; 42(5): 416–420.
- Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukaemia is most severly affected in the high risk group. Pediat Blood Cancer 2005; 44(4): 461–468.
- Mazur B, Szczepanski T, Karpe J, Jakimezyk DS, Bubala H, Torbus M. Decreased numbers of CD4 T-lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukaemia. Leukaemia Research 2006; 30(1): 33–36.
- Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992; 69: 1481–1486.
- Mackall CL, Hakim FT, Gress RE. T cell regeneration all repertoires are not created equal. Immunol Today 1997; 18(5): 245–251.
- Lovat PE, Robinson JH, Windebank KP, Kernahan J, Watson JG. Serial study of T lymphocytes in childhood leukaemia during remission. Pediat Haematol Oncol 1993; 10(2): 129–139.
- Haraldsson A, Vaan GAMD, Dijk WJV, et al. Light chains ratios and concentrations of immunoglobulins G, A, and M in childhood common acute lymphoblastic leukaemia. Peadiatr Haematol Oncol 1994; 11: 83–90.
- Abrahamsson J, Marky I, Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow up. Acta Pediatric 1995; 84: 177–82.
- Smith S, Schiffma G, Karayalcin G, Bonagura V. Immundiffeciency in long term survivors of acute lymphoblastic leukaemia treated with BFM therapy. J Pediatric 1995; 127(1): 68–75.
- Azuma E, Nagai M, Qi J. CD4 Tlymphocytopenia in long term survivors following intensive chemotherapy in childhood cancers. Med Pediatr Oncol 1998; 30(1): 40–45.
- Nilsson A, de Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukaemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002; 109(6): e91.
- Lex C, Korholz DF, Kolmuller B, et al. Infectious complications in children with acute lymphoblastic leukaemia and T cell lympho-poma; a rationable for tailored supportive care. Support Care Cancer 2001; 9(7): 514–512.
- Pizzo PA, Rubin M, Freifeld A, et al. The child with cancer and infection. I, Empiric therapy for fever and neutropenia and preventive strategies. J Pediatric 1991; 119(6): 845–857.
- Borzy MS, Ridgway D. Prolonged defects of interleukin 2 production, responsivness and receptor expression in patients with acute lymphoblastic leukaemia. Blood 1989; 73: 1608–1614.